Individualised non-contrast MRI-based risk estimation and shared decision-making in men with a suspicion of prostate cancer: protocol for multicentre randomised controlled trial (multi-IMPROD V.2.0)

INTRODUCTION: European Association of Urology and UK National Institute for Health and Care Excellence guidelines recommend that all men with suspicions of prostate cancer should undergo prebiopsy contrast enhanced, that is, multiparametric prostate MRI. Subsequent prostate biopsies should also be p...

Descripción completa

Detalles Bibliográficos
Autores principales: Ettala, Otto, Jambor, Ivan, Montoya Perez, Ileana, Seppänen, Marjo, Kaipia, Antti, Seikkula, Heikki, Syvänen, Kari T, Taimen, Pekka, Verho, Janne, Steiner, Aida, Saunavaara, Jani, Saukko, Ekaterina, Löyttyniemi, Eliisa, Sjoberg, Daniel D, Vickers, Andrew, Aronen, Hannu, Boström, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Urology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9014036/
https://www.ncbi.nlm.nih.gov/pubmed/35428621
http://dx.doi.org/10.1136/bmjopen-2021-053118

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9014036/
https://www.ncbi.nlm.nih.gov/pubmed/35428621
http://dx.doi.org/10.1136/bmjopen-2021-053118

Ejemplares similares